Compound 1294
Identifiers
- Canonical SMILES:
COc1c(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cccc1-c1ccc(Cl)cc1
- IUPAC name:
3,5-dichloro-N-[[3-(4-chlorophenyl)-2-methoxyphenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide
- InChi:
InChI=1S/C27H21Cl3FNO4S/c1-36-27-19(3-2-4-23(27)18-7-9-20(28)10-8-18)16-32(15-17-5-11-22(31)12-6-17)37(34,35)25-14-21(29)13-24(30)26(25)33/h2-14,33H,15-16H2,1H3
- InChiKey:
KYBBQEDQJFYYFB-UHFFFAOYSA-N
External links
![]() 44595537 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 240 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.92 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 579.02 g/mol | |||
HBA | 5 | |||
HBD | 1 | |||
HBA + HBD | 6 | |||
AlogP | 7.62 | |||
TPSA | 66.84 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 240 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.92 | |
WO2009152082 | 240 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.33 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5267 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4365 | Glyburide | DB01016 | |
0.4278 | Evatanepag | DB12022 | |
0.4085 | AL5927 | DB03526 | |
0.3989 | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DB04588 | |
0.3960 | Repinotan | DB06506 | |
0.3958 | Sulfabenzamide | DB09355 | |
0.3956 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3938 | CGS-27023 | DB07556 | |
0.3931 | Saccharin | DB12418 | |
0.3913 | Avagacestat | DB11893 | |
0.3874 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.3839 | Vidupiprant | DB12272 | |
0.3830 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.3816 | UK-390957 | DB11719 |